• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肿瘤基质对乳腺癌药物反应的影响。

The impact of tumor stroma on drug response in breast cancer.

机构信息

Clinic for Gynecology, University of Halle, Halle/Saale, Germany.

Clinic for Gynecology, University of Halle, Halle/Saale, Germany.

出版信息

Semin Cancer Biol. 2015 Apr;31:3-15. doi: 10.1016/j.semcancer.2014.05.006. Epub 2014 Jun 6.

DOI:10.1016/j.semcancer.2014.05.006
PMID:24912116
Abstract

In the last two decades the breast cancer mortality rate has steadily declined, in part, due to the availability of better treatment options. However, drug resistance still remains a major challenge. Resistance can be an inherent feature of breast cancer cells, but can also arise from the tumor microenvironment. This review aims to focus on the modulatory effect of the tumor microenvironment on the differing response of breast cancer subtypes to targeted drugs and chemotherapy.

摘要

在过去的二十年中,乳腺癌死亡率稳步下降,部分原因是有了更好的治疗选择。然而,药物耐药性仍然是一个主要挑战。耐药性可能是乳腺癌细胞固有的特征,但也可能源于肿瘤微环境。本文旨在重点探讨肿瘤微环境对不同乳腺癌亚型对靶向药物和化疗反应的调节作用。

相似文献

1
The impact of tumor stroma on drug response in breast cancer.肿瘤基质对乳腺癌药物反应的影响。
Semin Cancer Biol. 2015 Apr;31:3-15. doi: 10.1016/j.semcancer.2014.05.006. Epub 2014 Jun 6.
2
Mithramycin A sensitizes therapy-resistant breast cancer stem cells toward genotoxic drug doxorubicin.光神霉素A使耐治疗的乳腺癌干细胞对基因毒性药物阿霉素敏感。
Transl Res. 2015 May;165(5):558-77. doi: 10.1016/j.trsl.2014.10.011. Epub 2014 Nov 1.
3
Regulation of the breast cancer stem cell phenotype by hypoxia-inducible factors.缺氧诱导因子对乳腺癌干细胞表型的调控
Clin Sci (Lond). 2015 Dec;129(12):1037-45. doi: 10.1042/CS20150451.
4
Potential molecular, cellular and microenvironmental mechanism of sorafenib resistance in hepatocellular carcinoma.索拉非尼耐药的潜在分子、细胞及微环境机制在肝细胞癌中的研究。
Cancer Lett. 2015 Oct 10;367(1):1-11. doi: 10.1016/j.canlet.2015.06.019. Epub 2015 Jul 10.
5
Association of breast cancer stem cells identified by aldehyde dehydrogenase 1 expression with resistance to sequential Paclitaxel and epirubicin-based chemotherapy for breast cancers.通过醛脱氢酶1表达鉴定的乳腺癌干细胞与乳腺癌序贯紫杉醇和表柔比星化疗耐药性的关联。
Clin Cancer Res. 2009 Jun 15;15(12):4234-41. doi: 10.1158/1078-0432.CCR-08-1479. Epub 2009 Jun 9.
6
Tumor microenvironment: Sanctuary of the devil.肿瘤微环境:恶魔的庇护所。
Cancer Lett. 2015 Nov 1;368(1):7-13. doi: 10.1016/j.canlet.2015.07.039. Epub 2015 Aug 11.
7
Targeting cancer stem cells to suppress acquired chemotherapy resistance.针对癌症干细胞以抑制获得性化疗耐药性。
Oncogene. 2014 Sep 4;33(36):4451-63. doi: 10.1038/onc.2013.411. Epub 2013 Oct 7.
8
Putting the brakes on breast cancer: therapeutic opportunities to bring cancer stem cells and the tumor microenvironment to a screeching halt.遏制乳腺癌:使癌症干细胞和肿瘤微环境戛然而止的治疗机遇。
Curr Drug Targets. 2010 Sep;11(9):1041-2. doi: 10.2174/138945010792006834.
9
Does Chemotherapy Induce Metastases?化疗会引发转移吗?
Oncologist. 2018 Mar;23(3):273-274. doi: 10.1634/theoncologist.2017-0648.
10
Chemo-signal therapy, an emerging new approach to modify drug resistance in breast cancer.化学信号疗法,一种用于改变乳腺癌耐药性的新兴新方法。
Cancer Treat Rev. 1999 Oct;25(5):271-7. doi: 10.1053/ctrv.1999.0132.

引用本文的文献

1
Modeling Tumor Microenvironment Complexity In Vitro: Spheroids as Physiologically Relevant Tumor Models and Strategies for Their Analysis.体外模拟肿瘤微环境复杂性:球体作为生理相关肿瘤模型及其分析策略
Cells. 2025 May 17;14(10):732. doi: 10.3390/cells14100732.
2
Breast cancer patient-derived scaffolds enhance the understanding of PD-L1 regulation and T cell cytotoxicity.乳腺癌患者来源的支架增强了对PD-L1调节和T细胞细胞毒性的理解。
Commun Biol. 2025 Apr 16;8(1):621. doi: 10.1038/s42003-025-08054-3.
3
Exosome-Mediated Cellular Communication in the Tumor Microenvironment Imparts Drug Resistance in Breast Cancer.
外泌体介导的肿瘤微环境中的细胞通讯赋予乳腺癌耐药性。
Cancers (Basel). 2025 Mar 30;17(7):1167. doi: 10.3390/cancers17071167.
4
Contribution of Prediagnostic Host Factors to Shaping the Stromal Microenvironment of Breast Cancer among Sub-Saharan African Women.诊断前宿主因素对撒哈拉以南非洲女性乳腺癌基质微环境形成的影响
Cancer Epidemiol Biomarkers Prev. 2025 Apr 3;34(4):462-473. doi: 10.1158/1055-9965.EPI-24-0390.
5
Multi-omics analysis defines 5-fluorouracil drug resistance in 3D HeLa carcinoma cell model.多组学分析确定了3D HeLa癌细胞模型中的5-氟尿嘧啶耐药性。
Bioresour Bioprocess. 2021 Dec 23;8(1):135. doi: 10.1186/s40643-021-00486-z.
6
Combining the tumor-stroma ratio with tumor-infiltrating lymphocytes improves the prediction of pathological complete response in breast cancer patients.将肿瘤基质比与肿瘤浸润淋巴细胞相结合,可提高乳腺癌患者病理完全缓解预测的准确性。
Breast Cancer Res Treat. 2023 Nov;202(1):173-183. doi: 10.1007/s10549-023-07026-7. Epub 2023 Aug 1.
7
The role of tumor microenvironment in drug resistance: emerging technologies to unravel breast cancer heterogeneity.肿瘤微环境在耐药性中的作用:揭示乳腺癌异质性的新兴技术
Front Oncol. 2023 May 17;13:1170264. doi: 10.3389/fonc.2023.1170264. eCollection 2023.
8
Identifying biomarkers of differential chemotherapy response in TNBC patient-derived xenografts with a CTD/WGCNA approach.采用CTD/WGCNA方法在三阴乳腺癌患者来源的异种移植模型中鉴定化疗差异反应的生物标志物。
iScience. 2022 Dec 12;26(1):105799. doi: 10.1016/j.isci.2022.105799. eCollection 2023 Jan 20.
9
A CAF-Fueled TIMP-1/CD63/ITGB1/STAT3 Feedback Loop Promotes Migration and Growth of Breast Cancer Cells.一种由CAF驱动的TIMP-1/CD63/ITGB1/STAT3反馈环促进乳腺癌细胞的迁移和生长。
Cancers (Basel). 2022 Oct 11;14(20):4983. doi: 10.3390/cancers14204983.
10
Biological effects and regulation of IGFBP5 in breast cancer.IGFBP5 在乳腺癌中的生物学作用和调控。
Front Endocrinol (Lausanne). 2022 Aug 25;13:983793. doi: 10.3389/fendo.2022.983793. eCollection 2022.